New considerations in the design of clinical trials for amyotrophic lateral sclerosis
about
Clinical Trial Designs in Amyotrophic Lateral Sclerosis: Does One Design Fit All?The National ALS Registry: a recruitment tool for research.Delayed disease onset and extended survival in the SOD1G93A rat model of amyotrophic lateral sclerosis after suppression of mutant SOD1 in the motor cortexQuantifying disease progression in amyotrophic lateral sclerosis.Phase I trial of repeated intrathecal autologous bone marrow-derived mesenchymal stromal cells in amyotrophic lateral sclerosisCovariate-adjusted borrowing of historical control data in randomized clinical trials.Gene therapy for misfolding protein diseases of the central nervous system.Current options for drug delivery to the spinal cord.The Combined Assessment of Function and Survival (CAFS): a new endpoint for ALS clinical trials.Moving forward in clinical trials for ALS: motor neurons lead the way please.A retrospective review of the progress in amyotrophic lateral sclerosis drug discovery over the last decade and a look at the latest strategies.Use of clinical staging in amyotrophic lateral sclerosis for phase 3 clinical trials.Estimating clinical stage of amyotrophic lateral sclerosis from the ALS Functional Rating Scale.Status and perspectives of neuroprotective therapies in glaucoma: the European Glaucoma Society White Paper.Motoneuron Disease: Clinical.Trajectories of impairment in amyotrophic lateral sclerosis: Insights from the Pooled Resource Open-Access ALS Clinical Trials cohort.Peripheral nerve diffusion tensor imaging as a measure of disease progression in ALS.Factors affecting longitudinal functional decline and survival in amyotrophic lateral sclerosis patients.Comparing methods to combine functional loss and mortality in clinical trials for amyotrophic lateral sclerosis.Clinical Staging of Amyotrophic Lateral Sclerosis in Chinese Patients.
P2860
Q26823418-862ED08A-978E-4ECF-A13E-E1A91C34DE83Q34389199-662EE084-35EB-4841-8FD9-00B5E32346C4Q34983540-AA99E661-02E3-47F8-8358-F6276EC4B6FEQ35008605-170C5025-AFF0-4D0E-B9B8-EAC3CCBFE1B2Q35665302-2A7FE8E0-ED82-47DE-BF75-E5AFACBF98EFQ36385882-DA6F247C-55E2-4095-BE11-27B5F15321D8Q36983203-4AABBBDC-D979-4CCE-BDD5-3AF4F618CB44Q38071680-70883A2D-1DF2-4925-972C-6410A577983BQ38074456-2C190903-04BE-457B-A49D-300345077002Q38156505-44F332C0-DF4D-46C3-8391-F2BCDFC00159Q38573829-D895C938-0919-4F95-8E0F-179590563CA6Q39264219-6A6F9C5A-5EC6-4DF5-94DE-FB7C0537C0D2Q43494459-92C71F77-2489-4484-9163-6A2EB916620EQ45786530-3E518CBF-BEE8-42B4-842D-8AE08A1C4FA1Q45869420-24087AE0-B712-4DC7-A51B-574169C529C3Q47680014-D10234D2-D455-4241-A908-323878B941FCQ48278519-431CEFEE-AB59-4F3F-A958-322CCBB5FC8CQ51066498-52A87F24-7AD2-4049-AF03-B77580EBF508Q51733178-0EEC242C-BCF4-447E-BEC5-FA030D934927Q55443790-64561E68-14CB-49F8-846C-3897FCD5F995
P2860
New considerations in the design of clinical trials for amyotrophic lateral sclerosis
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
New considerations in the design of clinical trials for amyotrophic lateral sclerosis
@ast
New considerations in the design of clinical trials for amyotrophic lateral sclerosis
@en
type
label
New considerations in the design of clinical trials for amyotrophic lateral sclerosis
@ast
New considerations in the design of clinical trials for amyotrophic lateral sclerosis
@en
prefLabel
New considerations in the design of clinical trials for amyotrophic lateral sclerosis
@ast
New considerations in the design of clinical trials for amyotrophic lateral sclerosis
@en
P2860
P356
P1476
New considerations in the design of clinical trials for amyotrophic lateral sclerosis
@en
P2093
James D Berry
P2860
P304
P356
10.4155/CLI.11.127
P577
2011-10-01T00:00:00Z